Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

about

Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

Item

http://www.wikidata.org/entity/Q36508230

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

@ast

Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

@en

type

Item

label

Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

@ast

Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

@en

prefLabel

Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

@ast

Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

@en

P1476

Omitting or reducing radiotherapy in childhood or adolescence Hodgkin Lymphoma.

@en

P2093

Georgios Boutsikas

http://www.w3.org/2001/XMLSchema#string

Theodoros P Vassilakopoulos

http://www.w3.org/2001/XMLSchema#string

Vassilios Papadakis

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced and relapsed/refractory Hodgkin lymphoma: what has been achieved during the last 50 years

Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks

The case for chemotherapy alone for limited-stage Hodgkin's lymphoma.

Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group

Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.

ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.

P304

126-130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3978/J.ISSN.2224-4336.2013.06.03

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249657529

http://www.w3.org/2001/XMLSchema#string

P698

26835304

http://www.w3.org/2001/XMLSchema#string

P921

adolescence

P932

4728930

http://www.w3.org/2001/XMLSchema#string